tm logo
SAMSCA (TOLVAPTAN)
Live/Registered
REGISTERED

on 01 Nov 2022

Last Applicant/ Owned by

2-9 Kanda-Tsukasamachi,

Chiyoda-ku, Tokyo,

JP

101-8535

Serial Number

97022225 filed on 10th Sep 2021

Registration Number

6888096 registered on 01st Nov 2022

in the Principal Register

Correspondent Address

Scott S. Havlick

Scott S. Havlick

P.O. BOX 8749

ATTN: TRADEMARK DOCKETING

DENVER, CO, 80201

Filing Basis

No Filing Basis

Disclaimer

NO DATA

SAMSCA (TOLVAPTAN)

Pharmaceutical preparations for the treatment of hyponatremia, in patients with Syndrome of Inappropriate Antidiuretic Hormone (SIADH), heart failure and cirrhosis, namely, Tolvaptan

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the treatment of hyponatremia, in patients with Syndrome of Inappropriate Antidiuretic Hormone (SIADH), heart failure and cirrhosis, namely, Tolvaptan

Mark Details


Serial Number

No 97022225

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 57182.0401

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

01.15.08 -

A single drop (including a single raindrop or a single teardrop)

26.17.09 -

Curved line(s), band(s) or bar(s)

Legal History


Show more

Status DateAction Taken
01st Nov 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
01st Nov 2022REGISTERED-PRINCIPAL REGISTER
16th Aug 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
16th Aug 2022PUBLISHED FOR OPPOSITION
27th Jul 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12th Jul 2022APPROVED FOR PUB - PRINCIPAL REGISTER
09th Jul 2022TEAS/EMAIL CORRESPONDENCE ENTERED
08th Jul 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
08th Jul 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
28th Apr 2022NOTIFICATION OF PRIORITY ACTION E-MAILED